Balancing Chemical Equations
... A balanced equation shows the relationship between the quantities of all reactants and products. ...
... A balanced equation shows the relationship between the quantities of all reactants and products. ...
Biotechnology - Education Vijay
... the Neolithic Revolution. Through early biotechnology, the earliest farmers selected and bred the best suited crops, having the highest yields, to produce enough food to support a growing population. As crops and fields became increasingly large and difficult to maintain, it was discovered that spec ...
... the Neolithic Revolution. Through early biotechnology, the earliest farmers selected and bred the best suited crops, having the highest yields, to produce enough food to support a growing population. As crops and fields became increasingly large and difficult to maintain, it was discovered that spec ...
Research and Development at Sun Pharma
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
Party DRUGS - Australian Doctor
... and sensation, and its stimulant properties include mood elevation and increased energy levels. It has been called an ‘empathogen’ because it heightens communication, closeness and intimacy between individuals. While MDMA increases levels of both dopamine and noradrenaline in the brain, its primary ...
... and sensation, and its stimulant properties include mood elevation and increased energy levels. It has been called an ‘empathogen’ because it heightens communication, closeness and intimacy between individuals. While MDMA increases levels of both dopamine and noradrenaline in the brain, its primary ...
Research and Development at Sun Pharma
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
Research and Development at Sun Pharma
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
... Key features of technology for cytotoxic substances Avoids toxic excipients Better safety index as proven in animal model Increases circulation half life and improved efficacy More drugs can be delivered at target site Avoids hypersensitivity reaction to toxic excipients Uses all approved ex ...
FIXED DOSE COMBINATION PRODUCTSOF ANTI-HYPERTENSIVE’SAND ANTI-DIABETIC’S -
... Fixed Dose Combination (FDC) products are medicines that contain two or more active ingredients in a fixed ratio of doses in the same formulation [1, 2]. FDCs are formulated to have a similar bioequivalence of the two agents as separate tablets and therefore have similar pharmacokinetic and pharmaco ...
... Fixed Dose Combination (FDC) products are medicines that contain two or more active ingredients in a fixed ratio of doses in the same formulation [1, 2]. FDCs are formulated to have a similar bioequivalence of the two agents as separate tablets and therefore have similar pharmacokinetic and pharmaco ...
Introductory Review
... homogeneous sugar solution by evaporating off the solvent water. A sugar/sand mixture could be separated by dissolving the sugar in water, drying the sand, and reclaiming the sugar by evaporation of the solution. In the physical separation process, there has been no change in the composition of each ...
... homogeneous sugar solution by evaporating off the solvent water. A sugar/sand mixture could be separated by dissolving the sugar in water, drying the sand, and reclaiming the sugar by evaporation of the solution. In the physical separation process, there has been no change in the composition of each ...
Anti-inflammatory, Antirheumatoid and Related Agents
... GI lesions or peptic ulcer disease Bleeding disorders ...
... GI lesions or peptic ulcer disease Bleeding disorders ...
Lecture 17- Antifungal Agents
... Polyene Macrolide Antibiotics The discovery of nystatin (fungicidin) by Rachel Brown and Elizabeth Hazen in the early 1950s had led to the isolation and characterization of numerous antibiotics. Amphotericin B (fungizone), first isolated in the 1957 from Streptomyces nodosus, an actinomycete cultur ...
... Polyene Macrolide Antibiotics The discovery of nystatin (fungicidin) by Rachel Brown and Elizabeth Hazen in the early 1950s had led to the isolation and characterization of numerous antibiotics. Amphotericin B (fungizone), first isolated in the 1957 from Streptomyces nodosus, an actinomycete cultur ...
myRIS DRUGS & BIOLOGICS
... raise the question because the sheer magnitude of this unexplained research spending raises the possibility that something big has been missed. For the industry as a whole, the picture is the same: the average output since 2000 is 27 new drug per year, also with a flat trend. The annual R&D spending ...
... raise the question because the sheer magnitude of this unexplained research spending raises the possibility that something big has been missed. For the industry as a whole, the picture is the same: the average output since 2000 is 27 new drug per year, also with a flat trend. The annual R&D spending ...
Neumed, Inc. - Bio Korea Website
... University of Pennsylvania School of Medicine (USA), and others. ...
... University of Pennsylvania School of Medicine (USA), and others. ...
fast dissolving films - Asian Journal of Pharmaceutical Science and
... In the recent years, many of the pharmaceutical groups are focusing their research on rapid dissolving technology. This technology evolved over the past few years from the confection and oral care markets in the form of breath strips and became a novel and widely accepted form by consumers, so OFDFs ...
... In the recent years, many of the pharmaceutical groups are focusing their research on rapid dissolving technology. This technology evolved over the past few years from the confection and oral care markets in the form of breath strips and became a novel and widely accepted form by consumers, so OFDFs ...
comments of challengers who disputed the consistency argument
... 4. new drugs need to have proven efficacy. Hfowever, once approved, further studies may show efficacy in other diseases (in my case, other cancers) but to get FDA approval for every use would be cumbersome and slow for new treatments. It needs to cross the FDA hurdle initially, then show efficacy in ...
... 4. new drugs need to have proven efficacy. Hfowever, once approved, further studies may show efficacy in other diseases (in my case, other cancers) but to get FDA approval for every use would be cumbersome and slow for new treatments. It needs to cross the FDA hurdle initially, then show efficacy in ...
Uppers, Downers, All Arounders, 7th Edition
... Secondary prevention seeks to halt drug use once it has begun and adds intervention strategies to education and skill building. Drug diversion programs (e.g., drug courts) for first-time drug offenders have proven to be useful and cost-effective. Selective prevention at this level targets non-depend ...
... Secondary prevention seeks to halt drug use once it has begun and adds intervention strategies to education and skill building. Drug diversion programs (e.g., drug courts) for first-time drug offenders have proven to be useful and cost-effective. Selective prevention at this level targets non-depend ...
Chapter 12- Enemy Agents
... muscle fiber types, both of which will adversely affect performance. Alcohol also hinders the muscle’s ability to replenish energy stores, which may increase recovery time or compromise rehab after an injury. In addition, athletes who use alcohol have twice the injury rate as non-alcohol users. In a ...
... muscle fiber types, both of which will adversely affect performance. Alcohol also hinders the muscle’s ability to replenish energy stores, which may increase recovery time or compromise rehab after an injury. In addition, athletes who use alcohol have twice the injury rate as non-alcohol users. In a ...
61 Management of female incontinence - Aug 2015
... No difference in the clinical efficacy between OAB drugs. No evidence that one treatment is better than another. More expensive OAB drugs do not mean they are more effective. The lowest cost drug should be used (see Appendix B for full details): o 1st line = oxybutynin IR or tolterodine IR* o 2nd li ...
... No difference in the clinical efficacy between OAB drugs. No evidence that one treatment is better than another. More expensive OAB drugs do not mean they are more effective. The lowest cost drug should be used (see Appendix B for full details): o 1st line = oxybutynin IR or tolterodine IR* o 2nd li ...
molar mass - WordPress.com
... The molar mass of elements is found by looking at the atomic mass of the element on the periodic table. For example, if you want to find the molar mass of carbon, you would find the atomic mass of carbon on the periodic table, and this is equal to the molar mass in grams per mole. So, in our examp ...
... The molar mass of elements is found by looking at the atomic mass of the element on the periodic table. For example, if you want to find the molar mass of carbon, you would find the atomic mass of carbon on the periodic table, and this is equal to the molar mass in grams per mole. So, in our examp ...
Chapter 6 Chemical Composition
... • One amu is one-twelfth of the mass of a 12C atom • One amu is close to the mass of one proton or one neutron. • One amu is a very small mass – 1.66 x 10-24 g • One mole is 6.022 x 1023 units of anything • One mole (of atoms) of an element will have a mass in grams equal to the mass in amu of one a ...
... • One amu is one-twelfth of the mass of a 12C atom • One amu is close to the mass of one proton or one neutron. • One amu is a very small mass – 1.66 x 10-24 g • One mole is 6.022 x 1023 units of anything • One mole (of atoms) of an element will have a mass in grams equal to the mass in amu of one a ...
SYALLABUS OF B. PHARM. (REGULAR) 4 YEAR PROGRAM
... ability. Possibility, motivational & scope for self learning Pharmaceutical science helps identify preferred of optimal methods to deliver or dose a drug and reliably ensure therapeutic benefit with minimal side effects at the physiological site of action or disease. The field requires high level sc ...
... ability. Possibility, motivational & scope for self learning Pharmaceutical science helps identify preferred of optimal methods to deliver or dose a drug and reliably ensure therapeutic benefit with minimal side effects at the physiological site of action or disease. The field requires high level sc ...
Drug Delivery System based on MEMS Technology
... fragments after activation. These fragments exhibit a very limited impact on the surrounding tissue at the moment of membrane bursting. The mass of a 400 x 400 x 0.2 um piece of silicon nitride with a density of 3.4 g/cm3 is 0.11 ng, which represents a very limited impact on the tissue around the de ...
... fragments after activation. These fragments exhibit a very limited impact on the surrounding tissue at the moment of membrane bursting. The mass of a 400 x 400 x 0.2 um piece of silicon nitride with a density of 3.4 g/cm3 is 0.11 ng, which represents a very limited impact on the tissue around the de ...
arrhythmias - ichapps.com
... in recovery from block between action potentials and no effect on conduction. The increased inactivation and slower unbinding kinetics result in the selective depression of conduction in depolarized cells. Little effect is seen on the ECG in normal sinus rhythm. Toxicity: Lidocaine is one of the lea ...
... in recovery from block between action potentials and no effect on conduction. The increased inactivation and slower unbinding kinetics result in the selective depression of conduction in depolarized cells. Little effect is seen on the ECG in normal sinus rhythm. Toxicity: Lidocaine is one of the lea ...
graduate school of pharmaceutical sciences faculty of
... nal and synthetic chemical literature. Laboratory practice in synthetic chemistry, heteroaromatic chemistry and medicinal chemistry is also provided. Outline of Research Activities The main research fields are as follows: 1. Development of efficient strategy for synthesis of heterocycles directed to ...
... nal and synthetic chemical literature. Laboratory practice in synthetic chemistry, heteroaromatic chemistry and medicinal chemistry is also provided. Outline of Research Activities The main research fields are as follows: 1. Development of efficient strategy for synthesis of heterocycles directed to ...
Medicines that are Not Suitable for Generic Prescribing
... generically, providing particular attention is paid to particle size variations in formulation and bioavailability. Breath actuated, or dry powder, inhalers should be prescribed by brand name or generic name + device as instructions for use often vary between preparations. ...
... generically, providing particular attention is paid to particle size variations in formulation and bioavailability. Breath actuated, or dry powder, inhalers should be prescribed by brand name or generic name + device as instructions for use often vary between preparations. ...
FDA_Stop_Use_of_Ractopamineractopamine_1212.pdf
... developing their MRL for ractopamine in pig tissue. We are aware that FDA’s rationale for not using the most sensitive species, e.g. dog, was that the rhesus monkey 24-hour clearance rate for an oral dose of ractopamine via urine was closer to that of humans compared to dogs, e.g. 42% and 45% versus ...
... developing their MRL for ractopamine in pig tissue. We are aware that FDA’s rationale for not using the most sensitive species, e.g. dog, was that the rhesus monkey 24-hour clearance rate for an oral dose of ractopamine via urine was closer to that of humans compared to dogs, e.g. 42% and 45% versus ...
Drug discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, ""expensive, difficult, and inefficient process"" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity (NME) was approximately US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The ""final product"" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.